Gelex

Commission Implementing Decision of 14 July 2014 on authorising the placing on the market of oil from the micro-algae Schizochytrium sp. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council and repealing Decisions 2003/427/EC and 2009/778/EC (notified under document C(2014) 4670) (Only the English text is authentic) (2014/463/EU)

In forceVersion 2014-07-14from 2014-07-16
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2014/463@2014-07-14/en

Contents
  1. Preamble
    1. Article 1
    2. Article 2
    3. Article 3
    4. Article 4
  3. ANNEX
  4. ANNEX I SPECIFICATION OF OIL FROM THE MICRO-ALGAE SCHIZOCHYTRIUM SP.
  5. ANNEX II AUTHORISED USES OF OIL FROM THE MICRO-ALGAE SCHIZOCHYTRIUM SP.

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients, and in particular Article 7 thereof,

Whereas:

(1) The specification of oil from micro-algae Schizochytrium sp. has been laid down and its placing on the market has been authorised in several foods at certain maximum use levels by Commission Decision 2003/427/EC. The first extension of uses of oil from micro-algae Schizochytrium sp. has been granted by Commission Decision 2009/778/EC.

(2) On 16 January 2013, the company DSM Nutritional Products made a request to the competent authorities of the United Kingdom for extension of uses of oil from micro-algae Schizochytrium sp. as a novel food ingredient. DSM Nutritional Products has acquired company Martek Biosciences, who was the addressee of the previous decisions, by contract dated 30 June 2012.

(3) On 29 April 2013, the competent food assessment body of the United Kingdom issued its initial assessment report. In that report it came to the conclusion that the extension of uses of this algal oil meets the criteria for novel food set out in Article 3(1) of Regulation (EC) No 258/97.

(4) On 9 July 2013, the Commission forwarded the initial assessment report to the other Member States.

(5) Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation (EC) No 258/97. In particular, objections that concerned elevated intake levels of docosahexaenoic acid (DHA) were raised. In accordance with Article 7(1) of Regulation (EC) No 258/97 a Commission Implementing Decision should be made that takes into account the objections raised. The applicant consequently modified the request concerning the maximum amount of DHA in food supplements. This change and additional explanations provided by the applicant alleviated the concerns to the satisfaction of Member States and the Commission.

(6) Directive 2002/46/EC of the European Parliament and of the Council lays down requirements on food supplements. Regulation (EC) No 1925/2006 of the European Parliament and of the Council lays down requirements on the addition of vitamins and minerals and of certain other substances to foods. Directive 2009/39/EC of the European Parliament and of the Council lays down requirements on foodstuffs intended for particular nutritional uses. Commission Directive 96/8/EC lays down requirements on foods intended for use in energy-restricted diets for weight reduction. The use of oil from the micro-algae Schizochytrium sp. should be authorised without prejudice to the requirements of those legislations.

(7) For reasons of legal clarity Decisions 2003/427/EC and 2009/778/EC should be repealed and replaced by this Decision.

(8) Notifications of the placing on the market of an ingredient substantially equivalent to the algal oil as authorised by Decisions 2003/427/EC and 2009/778/EC, which have been submitted to the Commission in accordance with Article 5 of Regulation (EC) No 258/97 remain valid.

(9) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

HAS ADOPTED THIS DECISION:

Article 1

Oil from the micro-algae Schizochytrium sp. as specified in Annex I may be placed on the market in the Union as a novel food ingredient for the uses defined and at the maximum levels established in the Annex II without prejudice to the provisions of Directive 2002/46/EC, Regulation (EC) No 1925/2006, Directive 2009/39/EC and Directive 96/8/EC.

Article 2

The designation of oil from the micro-algae Schizochytrium sp. authorised by this Decision on the labelling of the foodstuffs containing it shall be oil from the micro-algae Schizochytrium sp..

Article 3

Decisions 2003/427/EC and 2009/778/EC are hereby repealed.

Article 4

This Decision is addressed to DSM Nutritional Products, 6480 Dobbin Road, Columbia, MD 21045, USA.

Done at Brussels, 14 July 2014. For the Commission Tonio Borg Member of the Commission

ANNEX

ANNEX I SPECIFICATION OF OIL FROM THE MICRO-ALGAE SCHIZOCHYTRIUM SP.

Test Specification Acid value Not more than 0,5 mg KOH/g Peroxide value (PV) Not more than 5,0 meq/kg oil Moisture and volatiles Not more than 0,05 % Unsaponifiables Not more than 4,5 % Trans-fatty acids Not more than 1,0 % DHA content Not less than 32,0 %

ANNEX II AUTHORISED USES OF OIL FROM THE MICRO-ALGAE SCHIZOCHYTRIUM SP.

Food category Maximum use level of DHA Dairy products except milk-based drinks 200 mg/100 g or for cheese products 600 mg/100 g Dairy analogues except drinks 200 mg/100 g or for analogues to cheese products 600 mg/100 g Spreadable fat and dressings 600 mg/100 g Breakfast cereals 500 mg/100 g Food supplements 250 mg DHA per day as recommended by the manufacturer for normal population 450 mg DHA per day as recommended by the manufacturer for pregnant and lactating women Foods intended for use in energy-restricted diets for weight reduction as defined in Directive 96/8/EC 250 mg per meal replacement Other foods for particular nutritional uses as defined in Directive 2009/39/EC excluding infant and follow on formulae 200 mg/100 g Dietary foods for special medical purposes In accordance with the particular nutritional requirements of the persons for whom the products are intended Bakery products (breads and rolls), sweet biscuits 200 mg/100 g Cereal bars 500 mg/100 g Cooking fats 360 mg/100 g Non-alcoholic beverages (including dairy analogue and milk-based drinks) 80 mg/100 ml

Versions

  1. 2014-07-14

Cited by